{"title":"2025新药更新：最近的批准及其临床意义。","authors":"Kasper Lee, Nadia Khartabil","doi":"10.4140/TCP.n.2025.306","DOIUrl":null,"url":null,"abstract":"<p><p>With the increasing prevalence of polypharmacy, age-related physiological changes, and the need for individualized pharmacotherapy in older patients, understanding new drug approvals is crucial to optimizing medication management. This paper synthesizes the latest evidence and offers insights into prescribing considerations, potential drug-drug interactions, and strategies to mitigate adverse effects. We believe this work will be of significant interest to health care professionals, including pharmacists, physicians, and geriatric specialists, as they navigate the evolving landscape of pharmacotherapy in older adults.</p>","PeriodicalId":41635,"journal":{"name":"Senior Care Pharmacist","volume":"40 8","pages":"306-314"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2025 New Drug Update: Recent Approvals and Their Clinical Implications.\",\"authors\":\"Kasper Lee, Nadia Khartabil\",\"doi\":\"10.4140/TCP.n.2025.306\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>With the increasing prevalence of polypharmacy, age-related physiological changes, and the need for individualized pharmacotherapy in older patients, understanding new drug approvals is crucial to optimizing medication management. This paper synthesizes the latest evidence and offers insights into prescribing considerations, potential drug-drug interactions, and strategies to mitigate adverse effects. We believe this work will be of significant interest to health care professionals, including pharmacists, physicians, and geriatric specialists, as they navigate the evolving landscape of pharmacotherapy in older adults.</p>\",\"PeriodicalId\":41635,\"journal\":{\"name\":\"Senior Care Pharmacist\",\"volume\":\"40 8\",\"pages\":\"306-314\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Senior Care Pharmacist\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4140/TCP.n.2025.306\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Senior Care Pharmacist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2025.306","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
2025 New Drug Update: Recent Approvals and Their Clinical Implications.
With the increasing prevalence of polypharmacy, age-related physiological changes, and the need for individualized pharmacotherapy in older patients, understanding new drug approvals is crucial to optimizing medication management. This paper synthesizes the latest evidence and offers insights into prescribing considerations, potential drug-drug interactions, and strategies to mitigate adverse effects. We believe this work will be of significant interest to health care professionals, including pharmacists, physicians, and geriatric specialists, as they navigate the evolving landscape of pharmacotherapy in older adults.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
